BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roche V, Pigneur F, Tselikas L, Roux M, Baranes L, Djabbari M, Costentin C, Calderaro J, Laurent A, Rahmouni A. Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence. Eur Radiol. 2015;25:186-195. [PMID: 25120205 DOI: 10.1007/s00330-014-3363-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Dietrich CF, Tannapfel A, Jang H, Kim TK, Burns PN, Dong Y. Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification. Ultrasound in Medicine & Biology 2019;45:1-10. [DOI: 10.1016/j.ultrasmedbio.2018.06.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
2 European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. 2016;65:386-398. [PMID: 27085809 DOI: 10.1016/j.jhep.2016.04.001] [Cited by in Crossref: 201] [Cited by in F6Publishing: 153] [Article Influence: 33.5] [Reference Citation Analysis]
3 Nault JC, Blanc JF, Moga L, Calderaro J, Dao T, Guiu B, Hocquelet A, Paradis V, Salamé E, de Lédinghen V, Bourlière M, Bureau C, Ganne-Carrié N. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF BENIGN LIVER TUMOURS. Clin Res Hepatol Gastroenterol 2021;:101765. [PMID: 34333196 DOI: 10.1016/j.clinre.2021.101765] [Reference Citation Analysis]
4 Haring MPD, Cuperus FJC, Duiker EW, de Haas RJ, de Meijer VE. Scoping review of clinical practice guidelines on the management of benign liver tumours. BMJ Open Gastroenterol 2021;8:e000592. [PMID: 34362758 DOI: 10.1136/bmjgast-2020-000592] [Reference Citation Analysis]
5 Naganuma H, Ishida H, Ogawa M, Suzuki K. Visualization of draining vein in focal nodular hyperplasia by superb microvascular imaging: report of two cases. J Med Ultrasonics 2017;44:323-8. [DOI: 10.1007/s10396-017-0775-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
6 Hau HM, Atanasov G, Tautenhahn HM, Ascherl R, Wiltberger G, Schoenberg MB, Morgül MH, Uhlmann D, Moche M, Fuchs J, Schmelzle M, Bartels M. The value of liver resection for focal nodular hyperplasia: resection yes or no? Eur J Med Res 2015;20:86. [PMID: 26494164 DOI: 10.1186/s40001-015-0181-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Bartolotta TV, Vernuccio F, Taibbi A, Lagalla R. Contrast-Enhanced Ultrasound in Focal Liver Lesions: Where Do We Stand? Semin Ultrasound CT MR. 2016;37:573-586. [PMID: 27986175 DOI: 10.1053/j.sult.2016.10.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
8 Han H, Ji Z, Ding H, Zhang W, Zhang R, Wang W. Assessment of blood flow in the hepatic tumors using non-contrast micro flow imaging: Initial experience. CH 2019;73:307-16. [DOI: 10.3233/ch-180532] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Gulpinar B, Peker E, Kul M, Elhan AH, Haliloglu N. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features? Abdom Radiol (NY) 2019;44:2147-55. [PMID: 30863999 DOI: 10.1007/s00261-019-01963-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lee J, Jeong WK, Lim HK, Kim AY. Focal Nodular Hyperplasia of the Liver: Contrast-Enhanced Ultrasonographic Features With Sonazoid: Contrast-Enhanced US Features of Focal Nodular Hyperplasia With Sonazoid. J Ultrasound Med 2018;37:1473-80. [DOI: 10.1002/jum.14490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
11 Wang W, Liu JY, Yang Z, Wang YF, Shen SL, Yi FL, Huang Y, Xu EJ, Xie XY, Lu MD, Wang Z, Chen LD. Hepatocellular adenoma: comparison between real-time contrast-enhanced ultrasound and dynamic computed tomography. Springerplus. 2016;5:951. [PMID: 27386395 DOI: 10.1186/s40064-016-2406-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
12 Naganuma H, Ishida H, Ogawa M, Watanabe Y, Watanabe D, Ohyama Y, Watanabe T. Focal nodular hyperplasia: our experience of 53 Japanese cases. J Med Ultrason (2001). 2017;44:79-88. [PMID: 27550510 DOI: 10.1007/s10396-016-0734-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Negrão de Figueiredo G, Mueller-peltzer K, Schwarze V, Marschner C, Zhang L, Rübenthaler J, Siepmann T, Illigens B, Clevert D. Long-term study analysis of contrast-enhanced ultrasound in the diagnosis of focal nodular hyperplasia. CH 2020;74:441-52. [DOI: 10.3233/ch-190710] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sannier A, Cazejust J, Lequoy M, Cervera P, Scatton O, Rosmorduc O, Wendum D. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia. Liver Int 2016;36:1668-76. [PMID: 26969817 DOI: 10.1111/liv.13113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Taimr P, Klompenhouwer AJ, Thomeer MGJ, Hansen BE, Ijzermans JNM, de Man RA, de Knegt RJ. Can point shear wave elastography differentiate focal nodular hyperplasia from hepatocellular adenoma. J Clin Ultrasound 2018;46:380-5. [PMID: 29740826 DOI: 10.1002/jcu.22603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Wang DC, Jang H, Kim TK. Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence? American Journal of Roentgenology 2020;214:1295-304. [DOI: 10.2214/ajr.19.21498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
17 Zhu M, Li H, Wang C, Yang B, Wang X, Hou F, Yang S, Wang Y, Guo X, Qi X. Focal nodular hyperplasia mimicking hepatocellular adenoma and carcinoma in two cases. Drug Discov Ther 2021;15:112-7. [PMID: 33952777 DOI: 10.5582/ddt.2021.01033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115 [PMID: 27660679 DOI: 10.4254/wjh.v8.i26.1110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Gregory J, Paisant A, Paulatto L, Raynaud L, Bertin C, Kerbaol A, Vullierme MP, Paradis V, Vilgrain V, Ronot M. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas. Eur J Radiol 2020;128:109027. [PMID: 32361381 DOI: 10.1016/j.ejrad.2020.109027] [Reference Citation Analysis]
20 Bröker MEE, Taimr P, de Vries M, Braun LMM, de Man RA, Ijzermans JNM, Dwarkasing RS. Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia. AJR Am J Roentgenol 2020;214:81-9. [PMID: 31573852 DOI: 10.2214/AJR.19.21251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Cociorvei A. Abdominal Contrast Enhanced Ultrasound, A Practical Review. Internal Medicine 2019;16:37-46. [DOI: 10.2478/inmed-2019-0092] [Reference Citation Analysis]
22 Myers L, Ahn J. Focal Nodular Hyperplasia and Hepatic Adenoma: Evaluation and Management. Clin Liver Dis 2020;24:389-403. [PMID: 32620279 DOI: 10.1016/j.cld.2020.04.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Hamada K, Saitoh S, Nishino N, Fukushima D, Techigawara K, Koyanagi R, Horikawa Y, Shiwa Y, Sakuma H, Kondo F. An elderly man with progressive focal nodular hyperplasia. Clin J Gastroenterol 2020;13:413-20. [PMID: 31768882 DOI: 10.1007/s12328-019-01072-9] [Reference Citation Analysis]
24 Benoit C, Rodrigues A, Calderaro J, Charpy C, Simonin S, Deybach JC, Gouya L, Puy H, Schmitt C, Farcy R, Vilgrain V, Paradis V, Pote N, Lafdil F, Mule S, Itti E, Luciani A. Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors. Eur Radiol 2021. [PMID: 34694452 DOI: 10.1007/s00330-021-08307-9] [Reference Citation Analysis]
25 Tselikas L, Pigneur F, Roux M, Baranes L, Costentin C, Roche V, Calderaro J, Herin E, Laurent A, Zafrani E. Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors. Abdom Radiol (NY). 2017;42:825-832. [PMID: 27704147 DOI: 10.1007/s00261-016-0921-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
26 Shyu S, Ali SZ. Significance of hepatocyte atypia in liver fine needle aspiration. Diagn Cytopathol 2021. [PMID: 34459153 DOI: 10.1002/dc.24851] [Reference Citation Analysis]
27 Sun XL, Yao H, Men Q, Hou KZ, Chen Z, Xu CQ, Liang LW. Combination of acoustic radiation force impulse imaging, serological indexes and contrast-enhanced ultrasound for diagnosis of liver lesions. World J Gastroenterol 2017; 23(30): 5602-5609 [PMID: 28852319 DOI: 10.3748/wjg.v23.i30.5602] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
28 Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. J Magn Reson Imaging 2015;42:1249-58. [PMID: 25851028 DOI: 10.1002/jmri.24897] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
29 Dioguardi Burgio M, Ronot M, Salvaggio G, Vilgrain V, Brancatelli G. Imaging of Hepatic Focal Nodular Hyperplasia: Pictorial Review and Diagnostic Strategy. Semin Ultrasound CT MR. 2016;37:511-524. [PMID: 27986170 DOI: 10.1053/j.sult.2016.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
30 Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? Abdom Radiol (NY) 2018;43:1670-81. [PMID: 29110059 DOI: 10.1007/s00261-017-1377-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Yikilmaz A, George M, Lee EY. Pediatric Hepatobiliary Neoplasms. Radiologic Clinics of North America 2017;55:741-66. [DOI: 10.1016/j.rcl.2017.02.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
32 Khalili K, Atri M, Kim TK, Jang HJ. Recognizing the Role of the Reticuloendothelial System in the Late Phase of US Contrast Agents. Radiology 2021;298:287-91. [PMID: 33290174 DOI: 10.1148/radiol.2020203245] [Reference Citation Analysis]
33 Christofides D, Leen ELS, Averkiou MA. Improvement of the accuracy of liver lesion DCEUS quantification with the use of automatic respiratory gating. Eur Radiol 2016;26:417-24. [DOI: 10.1007/s00330-015-3797-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
34 Müller-Peltzer K, Rübenthaler J, Negrao de Figueiredo G, Clevert DA. [CEUS-diagnosis of benign liver lesions]. Radiologe 2018;58:521-7. [PMID: 29704011 DOI: 10.1007/s00117-018-0390-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Taimr P, Bröker MEE, Dwarkasing RS, Hansen BE, de Knegt RJ, De Man RA, IJzermans JNM. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound. Ultrasound Med Biol 2017;43:2144-50. [PMID: 28743375 DOI: 10.1016/j.ultrasmedbio.2017.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
36 Zarzour JG, Porter KK, Tchelepi H, Robbin ML. Contrast-enhanced ultrasound of benign liver lesions.Abdom Radiol (NY). 2018;43:848-860. [PMID: 29167944 DOI: 10.1007/s00261-017-1402-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
37 Fang C, Bernardo S, Sellars ME, Deganello A, Sidhu PS. Contrast-enhanced ultrasound in the diagnosis of pediatric focal nodular hyperplasia and hepatic adenoma: interobserver reliability. Pediatr Radiol 2019;49:82-90. [DOI: 10.1007/s00247-018-4250-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
38 Auer TA, Fischer T, Garcia SRM, Penzkofer T, Jung EM, Hamm B, Lerchbaumer MH. Value of contrast-enhanced ultrasound (CEUS) in Focal Liver Lesions (FLL) with inconclusive findings on cross-sectional imaging. Clin Hemorheol Microcirc 2020;74:327-39. [PMID: 31658052 DOI: 10.3233/CH-190718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]